SFRP5 and cardiovascular disorder: These above results showed that SFRP5, ApoA‐I, and HDL3‐C played a protective role in cardiovascular disease, which could effectively reduce the degree of atherosclerosis, prevent the occurrence of ISR, and improve the degree of ISR.